Thunder Bay Regional Health Sciences Centre

Thunder Bay, Ontario P7B 7C7

1 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Breast Cancer, Coronary Artery Disease, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Hip Fractures, Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Ischemic Stroke, Prostatic Neoplasms, Stenosis, Urothelial Cancer, Ventilator Associated Pneumonia

Studies at this site

• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
• MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles — Recruiting now
• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling
• Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer — Running, not enrolling
• HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial — Completed
• Tailored Antiplatelet Therapy Following PCI — Completed
• Albumin in Acute Ischemic Stroke Trial — Stopped early
• Phase 1 and 2 Study of PX-866 and Cetuximab — Completed
• Study of Knowledge Translation of Clinical Practice Guidelines for Ventilator Associated Pneumonia — Completed